NCT02776436 2026-02-17
REDEX
Leiden University Medical Center
Phase 1 Completed
Clinical Trials
10 trialsNCT05838716 2026-01-15
ViPER
University of Rochester
Phase 3 Recruiting
NCT06039371 2026-01-14
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
University of Washington
Phase 2 Recruiting
NCT06129851 2023-11-13
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
University of Kansas Medical Center
Phase 2 Not yet recruiting
NCT02713022 2023-11-08
Body Composition and White Adipose Tissue Inflammation
Memorial Sloan Kettering Cancer Center
Completed
NCT02704377 2023-09-15
Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT00634582 2018-07-06
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
Wake Forest University Health Sciences
Phase 2 Terminated
NCT00996749 2018-07-03
Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT00176579 2011-08-12
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
Rutgers, The State University of New Jersey
Completed
NCT00957606 2011-04-13
Osteoporosis
Odense University Hospital
Phase 3 Unknown